Stockreport

Relay Therapeutics Inc (RLAY) Reports Full Year 2023 Financial Results and Corporate Highlights [Yahoo! Finance]

Relay Therapeutics, Inc.  (RLAY) 
PDF Revenue Growth : Full year 2023 revenue increased to $25.5 million, up from $1.4 million in 2022. R&D Expenses : Research and development expenses rose to $330.0 mill [Read more]